Details of the Drug

General Information of Drug (ID: DM8EI0J)

Drug Name
SBT-20
Indication
Disease Entry ICD 11 Status REF
Huntington disease 8A01.10 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0Q6EH

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)